![Ate van der Zee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Ate van der Zee
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
ViciniVax BV
![]() ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands.
5
| Holding Company | Pharmaceuticals: Other | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ate van der Zee via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Groningen | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
University of Utrecht | College/University | Graduate Degree Graduate Degree | |
VenGen BV
![]() VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Investment Managers | Founder | |
UbiQ Bio BV
![]() UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Photonics Healthcare BV
![]() Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Medical Specialties | Founder | |
University of Amsterdam | College/University | Doctorate Degree | |
MeiraGTx Netherlands BV
![]() MeiraGTx Netherlands BV Pharmaceuticals: MajorHealth Technology MeiraGTx Netherlands BV operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases. It is into develop adeno-associated viral mediated gene therapy for patients with rheumatic conditions. The company was founded in 2005 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Nederland | 12 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Finance | 2 |
Consumer Non-Durables | 2 |
Operationeel
Founder | 8 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sterkste connecties
Insiders | |
---|---|
Alfred N. Nijkerk | 7 |
Janneke Meulenberg | 6 |
Toos Daemen | 3 |
Hans Nijman | 2 |
Jan C. Wilschut | 1 |
- Beurs
- Insiders
- Ate van der Zee
- Bedrijfsconnecties